Skip to Content
NorthShore is part of Endeavor Health Learn more ›

Mark S. Talamonti, M.D.

Mark S. Talamonti, M.D.

Mark S. Talamonti, M.D.

Oncologic Surgery, Pancreatic Cancer, Pancreaticobiliary Disease
  • Locations
    Locations
    A

    Endeavor Health Medical Group

    2650 Ridge Ave.
    Kellogg Cancer Center
    Evanston, IL 60201
    847.570.1700 847.503.4371 fax
    View Map: Google
    This location is wheelchair accessible.
  • In the News
    In the News

    Jan 2017

    • Jan242017
      Dr. Mark Talamonti: Surgical Advancements in Pancreatic Cancer

      Onc Live

      Mark S. Talamonti, MD, clinical professor, NorthShore University HealthSystem, discusses some of the recent surgical advancements in pancreatic cancer.

      Currently, the state of the art is that there are a few institutions and a few high-volume surgeons who are able to perform laparoscopic or robotic pancreaticoduodenectomy procedures with the technical efficiency to favorably compare with open pancreatic surgery. Today, the gold standard remains as an open pancreaticoduodenectomy for patients with localized cancer in the head of the pancreas.

      However, Talamonti believes that the technology will continue to evolve, training programs will become more formalized, and more surgeons will be able to - See more at: http://www.onclive.com/conference-coverage/gi-2017/dr-talamonti-on-surgical-advancements-in-pancreatic-cancer#sthash.KhHWsBcx.dpuf
      Mark S. Talamonti, MD, clinical professor, NorthShore University HealthSystem, discusses some of the recent surgical advancements in pancreatic cancer.

      Currently, the state of the art is that there are a few institutions and a few high-volume surgeons who are able to perform laparoscopic or robotic pancreaticoduodenectomy procedures with the technical efficiency to favorably compare with open pancreatic surgery. Today, the gold standard remains as an open pancreaticoduodenectomy for patients with localized cancer in the head of the pancreas.

      However, Talamonti believes that the technology will continue to evolve, training programs will become more formalized, and more surgeons will be able to - See more at: http://www.onclive.com/conference-coverage/gi-2017/dr-talamonti-on-surgical-advancements-in-pancreatic-cancer#sthash.KhHWsBcx.dpuf
      Mark S. Talamonti, MD, clinical professor, NorthShore University HealthSystem, discusses some of the recent surgical advancements in pancreatic cancer.

      Currently, the state of the art is that there are a few institutions and a few high-volume surgeons who are able to perform laparoscopic or robotic pancreaticoduodenectomy procedures with the technical efficiency to favorably compare with open pancreatic surgery. Today, the gold standard remains as an open pancreaticoduodenectomy for patients with localized cancer in the head of the pancreas.

      However, Talamonti believes that the technology will continue to evolve, training programs will become more formalized, and more surgeons will be able to - See more at: http://www.onclive.com/conference-coverage/gi-2017/dr-talamonti-on-surgical-advancements-in-pancreatic-cancer#sthash.KhHWsBcx.dpuf
      ark S. Talamonti, MD, clinical professor, NorthShore University HealthSystem, discusses some of the recent surgical advancements in pancreatic cancer. - See more at: http://www.onclive.com/conference-coverage/gi-2017/dr-talamonti-on-surgical-advancements-in-pancreatic-cancer#sthash.KhHWsBcx.dpuf
      ark S. Talamonti, MD, clinical professor, NorthShore University HealthSystem, discusses some of the recent surgical advancements in pancreatic cancer. - See more at: http://www.onclive.com/conference-coverage/gi-2017/dr-talamonti-on-surgical-advancements-in-pancreatic-cancer#sthash.KhHWsBcx.dpuf

      Dr. Mark Talamonti discusses recent surgical advancements in pancreatic cancer...Talamonti believes technology will evolve...and more surgeons will have the ability to...

    Sep 2015

    • Sep142015
      Kanzius radiofrequency cancer treatment headed to clinical trials

      Pittsburgh Post-Gazette

      Mark S. Talamonti, chairman of the department of surgery at NorthShore...said he’s been watching progress with Kanzius research for years with a personal interest in using nanoparticles to target and destroy the cancer with radio waves...

    May 2014

    Mar 2014

  • Social Media
    Social Media